By Hans Lewis, TMCnet Contributor
For the purpose of enabling QED’s drug development clients to more easily form partnerships with key biopharmaceutical companies, QED Pharmaceutical Services has licensed SASÂ (News – Alert) Clinical Data Integration. The win at QED, a global contract research organization (CRO) with offices in India and the United States, continues the strong market momentum for SAS Clinical Data Integration. SAS, the leader in business analytics software and services, offers a comprehensive portfolio of life sciences software solutions for pharmaceutical, biotechnology and medical device companies.
Dr. Ramana Kuchibhatla, QED founder said, “The availability of SAS Clinical Data Integration has made it possible for QED to efficiently implement complex data standards such as the CDISC standards. This allows us to help our clients – predominantly small and sometimes virtual biopharmaceutical companies – achieve important milestones despite their size. Compliance with the latest CDISC standards makes growing drug developers like our clients very attractive partners to large pharma companies that are looking to in-license successful drug development programs. The overall value created by SAS Clinical Data Integration to both QED as a service company and our clients by making them attractive partners and ensuring regulatory compliance is tremendous.”
QED also has uses other SAS products including SAS Enterprise Business Intelligence. With the continuous knowledge base created by these systems, QED can offer cost-effective services for its clients. “It’s as if we have designed an efficient mechanical engine, and now, with little modification for each clinical trial, we can crank out CDISC-compliant data and get our clients’ datasets output in regulatory submission-ready formats,” said Kuchibhatla.
SAS Clinical Data Integration provides the foundation organizations need to deliver safety, efficacy and strategic, cross-study analyses. The solution brings repeatability and automation to the industry need to transform, manage and verify the creation of data standards, such as those from CDISC. SAS Clinical Data Integration facilitates operational data management efficiencies that speed delivery of business insight from clinical information. Using SAS, companies are delivering cleaner, more standard data for analysis and submission. In order to provide rapid access to clinical data to accelerate analysis and decision making in clinical research, SAS Clinical Data Integration will provide interoperability with Medidata Rave using CDISC operational data model (ODM) standards.
Other SAS for Life Sciences customers include Alcon, AstraZeneca, Eli Lilly and Company, McKesson and Monsanto.
Read here about Medidata Solutions, a provider of SaaSÂ (News – Alert) based clinical development solutions, has stated that they have designed and released a new randomization and trial supply management (RTSM) solution – Medidata Balance.
View the Original article